U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599956) titled 'Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection' on May 14.
Brief Summary: The main goal of this project is to see if RADAR (a machine-learning AI model) can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Rheumatic Heart Disease
Intervention:
DIAGNOS...